A Study for Post-marketing Surveillance of Azilsartan Medoxomil/Chlorthalidone Fixed Dose Combination (FDC) in the Treatment of Participants With Essential Hypertension in South Korea

Essential hypertension

Effect of Breathing and Muscle Relaxation Technique in Individual With Essential Hypertension A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS The Effect of the Use of BATHE Interview Technique on Treatment Compliance in Hypertension Patients in Primary Care Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients A Phase 3 Study to Evaluate and Compare the Efficacy and Safety of 8-week Treatment With AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects Effect of Motivational Interviews on Cardiovascular Disease Risks and Healthy Lifestyle Behavior Changes Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension. Study MIPAE – Melatonin and Essential Arterial Hypertension Juvenile Essential Arterial Hypertension and Vascular Function Protective Effect of Beraprost Sodium Tablets on Reperfusion Therapy for Acute STEMI Physical Activity, Air Pollution, and High Blood Pressure s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension A Study for Post-marketing Surveillance of Azilsartan Medoxomil/Chlorthalidone Fixed Dose Combination (FDC) in the Treatment of Participants With Essential Hypertension in South Korea A Study for Post-Marketing Surveillance of Azilsartan Medoxomil in the Treatment of Adult Participants With Essential Hypertension in South Korea Effects of Aromatherapy in Hypertensive Individuals Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment The Northwest Coalition for Primary Care Practice Support Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure Resistant Arterial Hypertension Cohort Study Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Vascular Impact of Omega-3 in Metabolic Syndrome Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular Olmesartan Medoxomil in Atherosclerosis Olmesartan Medoxomil in Hypertension and Renal Impairment LCZ696 in Advanced LV Hypertrophy and HFpEF The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension Effect of Atorvastatin on Carotid Intima Media Thickness Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers The Confirmatory Olmesartan Plaque Regression Study Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control Motivational Interviewing Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy Non-pharmacological Treatment for Essential Isolated Systolic Hypertension in Elderly Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension Olmesartan as an add-on to Amlodipine in Hypertension Amlodipine as add-on to Olmesartan in Hypertension Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension Home Blood Pressure in Hypertension Management Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study RAS Peptide Profiles in Patients With Arterial Hypertension Treatment of HYpertension: Morning Versus Evening Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension. Evaluation of a Transmedial Psychoeducational Program to Improve Pharmacological Adherence Heat Therapy in Older Hypertensive Women FimasaRtan-basEd BP Targets After Drug SwitcHing Clinical Trial on Remote Ischemic Conditioning and Hypertension（HOPE） S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension Helius in Hypertension-I: The UK Hypertension Registry Fimasartan Achieving SBP Target (FAST) Study Personal Activity Intelligence in the Treatment of High Blood Pressure A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Early Morning Blood Pressure and Central Arterial Pressure Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects Effect of Acupuncture on Patients With Mild Hypertension Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones Hybrid Blood Pressure Monitor Validation A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects Hypertension: Prediction of Biofeedback Success The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb In-practice Evaluation of Atacand 16mg Antihypertensive Effect PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients. Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control Study of Efficacy and Safety of CVAA489 in Hypertensive Patients Olmesartan Medoxomil Versus Losartan in Patients With Hypertension Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan) Fimasartan/Amlodipine Combination Phase III Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension Heart Rate Variability in White Coat Hypertension and Essential Hypertension GRK4 Polymorphisms Blood Pressure Response to Candesartan The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine Perindopril Amlodipine for the Treatment of Hypertension Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension Loaded Breathing Training in Essential Hypertension Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia Vedic Medical Astrology in Essential Hypertension The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia Safety Study of RMJH-111b to Treat Essential Hypertension Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) Essential Hypertension Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension Intensive Vasodilator Therapy in Patients With Essential Hypertension Canrenone as Add-on in Patients With Essential Hypertension Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension Study of Personalized Dietary Intervention for the Control of Essential Hypertension Inflammatory Response to Salt in Essential Hypertension Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension Efficacy of Rostafuroxin in the Treatment of Essential Hypertension A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT) A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension Olmesartan in Essential Hypertension Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension Uric Acid in Essential Hypertension in Children Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension Study of CS-3150 in Patients With Essential Hypertension A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide Safety and Efficacy of Remote Ischemic Conditioning in Patients With Essential Hypertension (SERIC-EH) Renal Sympathetic Modification in Patients With Essential Hypertension Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension L-Arginine Metabolism in Essential Hypertension Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension